Conor Medsystems to Present at the A.G. Edwards Emerging Growth Conference
MENLO PARK, Calif., Sept. 14 -- Conor Medsystems, Inc. (Nasdaq: CONR - News) is scheduled to present at the A.G. Edwards Emerging Growth Conference on Wednesday, September 20, 2006 in New York. Frank Litvack, M.D., Chairman and CEO, will provide a corporate update at 2:15 p.m. Eastern Time.
To access the live audio broadcast or the subsequent archived recording, visit
the webcast section of the company's website located at www.conormed.com . The
recording will be archived for 30 days following the live presentation. Please
log on to Conor's website several minutes prior to the start of the presentation
to ensure adequate time for any software download that may be necessary.
About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com .
Source: Conor Medsystems, Inc. |
